REST and Alzheimer disease: Meyer and colleagues (Meyeret al., 2019) showed that changing theAPOE genotype from ε4 (AD risk factor) to ε3 (neutral genotype) in human NPCs can suppress premature neuronal differentiation and maturation via increasing the transcription repressor activity of RE1 silencing transcription factor (REST).